-
A prodrug of gabapentin has been approved by the FDA for the treatment of restless legs syndrome (RLS).
-
Interact included 404 patients with acute intracere-bral hemorrhage (ICH), elevated systolic blood pressure (BP) (150 to 220 mmHg), and capacity to lower BP within 6 hours of onset. CT was performed at baseline and at 24 hours to compare hematoma size.
-
It has been speculated that children growing up in an overly clean, suburban environment may experience greater atopy and asthma than children growing up in the inner city or on a farm.
-
In this issue: Calcium supplements and MI; birth control pills and VTE; ACE inhibitors and breast cancer risk; spending on pharmaceuticals; and FDA actions.
-
Although the annual incidence of all gynecological malignancies remains between 75,000 and 80,000, a far greater number of women with this history are survivors.
-
This publication is an update on osteoporosis screening from the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation.
-
Over the years, different tocolytics have been in vogue, only to be discarded later because meta-analyses showed that the agent simply did not work. This month's review will focus on nifedipine, a medication that has been in and out of favor for more than 20 years.
-
-
-
In the vulvar vestibulitis clinical trial conducted at the University of Rochester between 2002 and 2007, patients with vulvar vestibulitis syndrome (localized provoked vulvodynia) were enrolled in a 12-week randomized, placebo-controlled treatment trial.